Stockscreener 앱 받기
1.24
5.08%
0.06
시간 외 거래:
1.24
전일 마감가:
$1.18
열려 있는:
$1.17
하루 거래량:
4.48M
Relative Volume:
1.48
시가총액:
$202.09M
수익:
-
순이익/손실:
$-111.13M
주가수익비율:
-0.9394
EPS:
-1.32
순현금흐름:
$-91.53M
1주 성능:
+9.73%
1개월 성능:
+78.85%
6개월 성능:
+181.82%
1년 성능:
-49.18%
1일 변동 폭
$1.14
$1.26
1주일 범위
$1.05
$1.26
52주 변동 폭
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
명칭
Tenaya Therapeutics Inc
전화
415-865-2066
주소
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
TNYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.24 | 176.01M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-10 | 개시 | William Blair | Outperform |
| 2023-11-30 | 개시 | Leerink Partners | Outperform |
| 2022-06-15 | 개시 | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
Using AI based signals to follow Tenaya Therapeutics Inc.IPO Watch & Trade Opportunity Analysis - Newser
Is Tenaya Therapeutics Inc. a defensive stock2025 Year in Review & Fast Exit/Entry Strategy Plans - khodrobank.com
Will Tenaya Therapeutics Inc. see short term momentumJuly 2025 Update & Safe Entry Point Alerts - Newser
Earnings visualization tools for Tenaya Therapeutics Inc.Trade Exit Summary & Short-Term High Return Ideas - Newser
Risk Check: Is Tenaya Therapeutics Inc. a defensive stock2025 Volume Leaders & Community Trade Idea Sharing Platform - khodrobank.com
Is a relief rally coming for Tenaya Therapeutics Inc. holdersWeekly Stock Recap & Weekly High Return Forecasts - Newser
Historical volatility pattern of Tenaya Therapeutics Inc. visualizedJuly 2025 Fed Impact & Consistent Profit Trading Strategies - Newser
Tenaya Therapeutics shares rise 6.94% intraday after CEO to participate in Morgan Stanley conference. - AInvest
What’s next for Tenaya Therapeutics Inc. stock price2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Regression analysis insights on Tenaya Therapeutics Inc. performancePrice Action & Risk Managed Investment Signals - Newser
Signal strength of Tenaya Therapeutics Inc. stock in tech scanners2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
Is Tenaya Therapeutics Inc. part of any major indexBond Market & AI Enhanced Trading Alerts - khodrobank.com
What’s the recovery path for long term holders of Tenaya Therapeutics Inc.Weekly Trade Review & Weekly Top Gainers Trade List - Newser
How moving averages guide Tenaya Therapeutics Inc. tradingFed Meeting & Risk Managed Investment Entry Signals - Newser
Will Tenaya Therapeutics Inc. stock go up soon2025 Price Targets & Daily Market Momentum Tracking - Newser
News impact scoring models applied to Tenaya Therapeutics Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - Newser
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
Heart Disease Biotech Tenaya Therapeutics Featured at Morgan Stanley Global Healthcare Conference 2025 - Stock Titan
Best data tools to analyze Tenaya Therapeutics Inc. stock2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Will Tenaya Therapeutics Inc. rebound enough to break evenWeekly Risk Summary & Daily Technical Forecast Reports - Newser
Layoff Watch: Can Tenaya Therapeutics Inc. reach all time highs this yearBuy Signal & Fast Exit Strategy with Risk Control - khodrobank.com
Long term hold vs stop loss in Tenaya Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
What’s the analyst consensus on Tenaya Therapeutics Inc.Product Launch & Consistent Profit Alerts - khodrobank.com
Tenaya Therapeutics Inc. stock momentum explained2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser
How to read the order book for Tenaya Therapeutics Inc.2025 Price Targets & Community Consensus Picks - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookTrade Signal Summary & Daily Chart Pattern Signal Reports - Newser
Published on: 2025-09-01 18:04:09 - خودرو بانک
What earnings revisions data tells us about Tenaya Therapeutics IncBond Market & Long Hold Capital Preservation Tips - Newser
Volatility clustering patterns for Tenaya Therapeutics Inc.2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
Tenaya Therapeutics Inc.’s volatility index tracking explained2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Earnings visualization tools for Tenaya Therapeutics IncEarnings Beat & Target Return Focused Stock Picks - Newser
Volume spikes in Tenaya Therapeutics Inc. stock – what they meanQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-08-31 18:54:47 - Newser
Detecting support and resistance levels for Tenaya Therapeutics Inc.Market Activity Report & Target Return Focused Stock Picks - Newser
Why Tenaya Therapeutics Inc. is moving todayTrade Exit Summary & High Return Trade Opportunity Guides - Newser
Tenaya Therapeutics Presents MyClimb Natural History Study Interim Data at ESC Congress 2025: Largest Noninterventional Study on Pediatric MYBPC3-associated HCM Patients. - AInvest
Tenaya Therapeutics Presents Interim Data from MyClimb™ Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025 - GlobeNewswire
93% of Young Heart Disease Patients Have No Treatment Options: Landmark Tenaya Study of 213 Children - Stock Titan
What earnings revisions data tells us about Tenaya Therapeutics Inc.2025 Valuation Update & AI Based Buy and Sell Signals - Newser
Tenaya Therapeutics Inc (TNYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tenaya Therapeutics Inc 주식 (TNYA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
| Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
1.75%
1.11%
자본화:
|
볼륨(24시간):